Cheminformatics companies develop software and analytical tools for storing, searching and interpreting chemical and molecular data. These technologies support compound discovery, medicinal chemistry, materials research and pharmaceutical development.
This category includes companies working on:
Browse 31 UK cheminformatics companies below.
Targeting developmentally-silent oncogenic drivers for cancer therapy
Awen Oncology is a Welsh oncology biotechnology company developing first-in-class therapeutics that target cancer-specific proteins derived from developmental genes that are…
Automated chiral chemistry platform for small molecule drug discovery
LCC Technologies is a drug discovery company providing biopharma partners with access to its platform, which combines a proprietary billion-scale virtual chiral library with…
Structural chemistry database and software for drug discovery
The Cambridge Crystallographic Data Centre (CCDC) is a non-profit organisation that curates and distributes the Cambridge Structural Database (CSD), the world's repository of…
AI-driven automated flow chemistry platform for chemical process development
SOLVE Chemistry is a contract research and technology company providing AI-powered process development services to pharmaceutical, agrochemical, and specialty chemical…
Cloud-based informatics platform for drug discovery data management
Collaborative Drug Discovery (CDD) is a software company providing a cloud-based informatics platform for drug discovery research. Its flagship product enables scientists to…
Integrated outsourced drug discovery and development platform
RxCelerate is a contract research organisation providing fully integrated drug discovery and development services to pharmaceutical and biotech companies. Based at Babraham…
AI-driven combinatorial chemistry platform for next-generation RNA therapeutics
Eleven Therapeutics is a biotechnology company developing next-generation RNA therapeutics by combining combinatorial chemistry with artificial intelligence to map the vast…
AI platform engineering molecular glue drugs for undruggable targets
Ternary Therapeutics is a preclinical-stage biotechnology company developing an AI-driven platform for the rational design of molecular glue therapeutics. Molecular glues are…
In silico software and AI for small molecule drug discovery
Optibrium is a software company providing integrated computational platforms for small molecule design, optimisation and data analysis across preclinical drug discovery. Its tools…
AI and quantum-chemical platform for small-molecule drug design
Tres Alchemix is the UK subsidiary of a Japanese biotechnology company developing an AI-driven drug-design platform for small-molecule therapeutics. The platform integrates…
Generative AI platform for whole-organism biological modelling
AI Vivo is an early-stage Cambridge biotechnology company developing a generative AI system that constructs multi-scale biological models linking molecular targets through tissue…
AI platform for pharma drug discovery workflows
DaltonTx is a technology company building adaptive AI-enabled discovery platforms for the pharmaceutical industry. Its disease- and modality-agnostic platform integrates into…